Trevena Stock (NASDAQ: TRVN) stock price, news, charts, stock research, profile.
Open | $0.490 |
Close | $0.460 |
Volume / Avg. | 141.813K / 113.093K |
Day Range | 0.450 - 0.490 |
52 Wk Range | 0.407 - 3.280 |
Market Cap | $8.353M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 30 |
Short Interest | 0.4% |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Trevena (NASDAQ: TRVN) through any online brokerage.
Other companies in Trevena’s space includes: Virios Therapeutics (NASDAQ:VIRI), Monopar Therapeutics (NASDAQ:MNPR), Coeptis Therapeutics (NASDAQ:COEP), BioRestorative Therapies (NASDAQ:BRTX) and NexImmune (NASDAQ:NEXI).
The latest price target for Trevena (NASDAQ: TRVN) was reported by HC Wainwright & Co. on Monday, March 11, 2024. The analyst firm set a price target for 9.00 expecting TRVN to rise to within 12 months (a possible 1874.12% upside). 4 analyst firms have reported ratings in the last year.
The stock price for Trevena (NASDAQ: TRVN) is $0.4559 last updated March 28, 2024 at 7:53 PM EDT.
There are no upcoming dividends for Trevena.
Trevena does not have any upcoming earnings scheduled.
There is no upcoming split for Trevena.
Trevena is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.